CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea
Nam-Jun Cho, Dae-Yeon Kim, Soon Hyo Kwon, Tae Won Ha, Hyun Kyu Kim, Man Ryul Lee, Sung Wan Chun, Samel Park, Eun-young Lee, Hyo-Wook Gil
Kidney Res Clin Pract. 2021;40(3):383-391.   Published online July 7, 2021
DOI: https://doi.org/10.23876/j.krcp.21.015

Excel Download

Urinary exosomal microRNA profiling in type 2 diabetes patients taking dipeptidyl peptidase-4 inhibitor compared with sulfonylurea
Nam-Jun Cho, Dae-Yeon Kim, Soon Hyo Kwon, Tae Won Ha, Hyun Kyu Kim, Man Ryul Lee, Sung Wan Chun, Samel Park, Eun-young Lee, Hyo-Wook Gil
Kidney Research and Clinical Practice. 2021;40(3):383-391   Crossref logo
Link1 Link2 Link3
Treatment progression in sulfonylurea and dipeptidyl peptidase-4-inhibitor cohorts of type 2 diabetes patients on metformin
Xiaomei Peng, Dingfeng Jiang, Dongju Liu, Oralee Varnado, Jay Bae
Patient Preference and Adherence. 2016;Volume 10:1539-1546   Crossref logo
Link1
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial
M. A. Nauck, G. Meininger, D. Sheng, L. Terranella, P. P. Stein,
Diabetes, Obesity and Metabolism. 2007;9(2):194-205   Crossref logo
Link1 Link2
Lower Risk of Dementia in Elderly Patients Initiated on Dipeptidyl Peptidase-4 Inhibitor vs. Sulfonylurea—A Population-Based Cohort Study
SEUNG JIN HAN, JA YOUNG JEON, KWANWOO LEE, TAE HO KIM, HYUN UK MOON
Diabetes. 2018;67(Supplement_1):   Crossref logo
Link1 Link2
Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus
T. Kadowaki, K. Kondo
Diabetes, Obesity and Metabolism. 2013;15(9):810-818   Crossref logo
Link1 Link2
Combination Therapy with a Dipeptidyl peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA1c Levels in Japanese Patients with Type 2 Diabetes Mellitus
Koichi Hirao, Hajime Maeda, Shin-ichiro Shirabe, Ritsuko Yamamoto, Tetsuyuki Hirao, Setsuko Hirao, Mikio Yamauchi, Keiko Arai
Japanese Clinical Medicine. 2012;3:JCM.S8571   Crossref logo
Link1 Link2 Link3
A Comparative Study of the Effects of a Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability in Patients with Type 2 Diabetes with Inadequate Glycemic Control on Metformin
Hun-Sung Kim, Jeong-Ah Shin, Seung-Hwan Lee, Eun-Sook Kim, Jae-Hyoung Cho, Ho-Young Son, Kun-Ho Yoon
Diabetes Technology & Therapeutics. 2013;15(10):810-816   Crossref logo
Link1 Link2
500-P: The Performance of Four Different Exosome Isolation Methods for Urinary Exosomal microRNA Profiling in Patients with Diabetic Kidney Disease
KIYOUNG LEE, DAEHO LEE, IE BYUNG PARK
Diabetes. 2019;68(Supplement_1):   Crossref logo
Link1 Link2
Corrigendum to “Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease”
Yijun Xie, Yijie Jia, Cuihua Xie, Fang Hu, Meng Xue, Yaoming Xue
Journal of Diabetes Research. 2018;2018:1-1   Crossref logo
Link1 Link2 Link3
New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors
Chan-Hee Jung
Endocrinology and Metabolism. 2021;36(2):339-341   Crossref logo
Link1 Link2 Link3